Jacalyn Rosenblatt, MD

Beth Israel Deaconess Medical CenterBoston, Massachusetts - 02215 |
- CLINICAL TRIALS 7
- CONDITIONS19
- INTERVENTIONS15
- SINCE2004

Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod
August 2008 - December 2011

Reduced Intensity Conditioning With Clofarabine Antithymocyte Globulin (ATG) Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant
June 2008 - June 2011

Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian Fallopian Tube or Primary Peritoneal Cancer
September 2008 - December 2011

Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF
October 2004 - June 2011

Bortezomib Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma
August 2006 - August 2010

Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
April 2010 - March 2019

Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma
April 2005 - September 2011
Lymphoma
Lymphoma, Non-Hodgkin
Multiple Myeloma
Neoplasms, Plasma Cell
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphoid
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Leukemia, Myeloid, Acute
Leukemia, Myeloid
Myelodysplastic Syndromes
Preleukemia
Ovarian Neoplasms
Carcinoma, Renal Cell
Kidney Neoplasms
Peritoneal Neoplasms
Fallopian Tube Neoplasms
Hodgkin Disease
Graft vs Host Disease
Gm-Csf
Dendritic Cell/Tumor Fusion Vaccine
Imiquimod
Lenalidomide
Bortezomib
Dexamethasone
Clofarabine
Antithymocyte Globulin
Tumor Collection
Dendritic Cell Tumor Fusion Vaccine
Granulocyte Macrophage Colony Stimulating Factor (Gm-Csf)
Sirolimus + Calcineurin Inhibitor + Prednisone
Sirolimus + Prednisone
Sirolimus + Extracorporeal Photopheresis + Prednisone
Dendritic Cell Tumor Fusion



